Primary hyperfibrinolysis: Facts and fancies

Massimo Franchini, Pier Mannuccio Mannucci

Research output: Contribution to journalReview articlepeer-review


Fibrinolysis is a complex process that controls both hemostasis and thrombosis. The regulation of the fibrinolytic system is mediated through a wide array of cofactors and inhibitors that maintain the hemostatic balance in a delicate equilibrium. As a consequence, disturbances in the fibrinolysis pathway are associated with various disease states, ranging from thrombotic to hemorrhagic clinical phenotypes. In particular, a number of inherited and acquired disorders are associated with an enhanced fibrinolysis leading to a bleeding tendency that in some cases may be life-threatening. Hyperfibrinolysis has been classified into primary and secondary forms but such differentiation, which may have important treatment implications, is still controversial. This narrative review will be focused on inherited and acquired conditions associated with primary hyperfibrinolysis.

Original languageEnglish
Pages (from-to)71-75
Number of pages5
JournalThrombosis Research
Publication statusPublished - Jun 1 2018


  • Acquired
  • Antifibrinolytics
  • Bleeding
  • Inherited
  • Primary hyperfibrinolysis

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Primary hyperfibrinolysis: Facts and fancies'. Together they form a unique fingerprint.

Cite this